Assessment of DAPK1 and CAVIN3 Gene Promoter Methylation in Breast Invasive Ductal Carcinoma and Metastasis
for detection of distant metastasis have still some limitations. Blood tests may improve sensitivity and specificity of currently used screening procedures. The present study was designed to investigate promoter methylation status of DAPK1 and CAVIN3 genes in plasma circulating free DNA (cfDNA) samp...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Royan Institute (ACECR), Tehran
2021-09-01
|
| Series: | Cell Journal |
| Subjects: | |
| Online Access: | https://celljournal.org/journal/article/fulltext/assessment-of-dapk1-and-cavin3-genes-promoter-methylation-in-breast-invasive-ductal-carcinoma-incidence-and-metastasis.pdf |
| _version_ | 1819098840597266432 |
|---|---|
| author | Esmat Ghalkhani Mohammad Taghi Akbari Pantea Izadi Habibollah Mahmoodzadeh Fatemeh Kamali |
| author_facet | Esmat Ghalkhani Mohammad Taghi Akbari Pantea Izadi Habibollah Mahmoodzadeh Fatemeh Kamali |
| author_sort | Esmat Ghalkhani |
| collection | DOAJ |
| description | for detection of distant metastasis have still some limitations. Blood tests may improve sensitivity and specificity of currently used screening procedures. The present study was designed to investigate promoter methylation status of DAPK1 and CAVIN3 genes in plasma circulating free DNA (cfDNA) samples in Iranian invasive ductal carcinoma (IDC) patients. We also investigated association of two gene promoter methylations with breast cancer (BC) and metastatic BC was also assessed. Materials and Methods: In this case-control study, MethySYBR assay was performed to determine DAPK1 and CAVIN3 promoter methylation status in breast IDC from 90 patients and 30 controls. Based on clinicopathological information, patient samples subdivided into stage I, II/III and IV groups (each group contained 30 individuals). Results: According to the results an increased promoter methylation level of the DAPK1 gene in BC patients was observed. It was found that as disease progressed, the percentage of methylation was changed while it was not significant. Methylation changes in metastatic and non-metastatic BC revealed that methylation levels were significantly increased in metastatic than non-metastatic group. Analysis revealed that promoter methylation of CAVIN3 gene in BC patients was significantly increased. The observed methylation changes from less to more invasive stages were not significant in the CAVIN3 gene. Moreover, promoter methylation was changed in metastatic rather than non-metastatic condition, although it was not significant. Conclusion: Promoter hypermethylation of DAPK1 and CAVIN3 genes in plasma are associated with the risk of BC and they can be potential diagnostic biomarkers along with current methods. Additionally, association of aberrant
DAPK1 promoter methylation with metastasis suggests its potential usage as a non-invasive strategy for metastatic BC diagnosis. |
| first_indexed | 2024-12-22T00:37:23Z |
| format | Article |
| id | doaj.art-3d4896fa721149aaa589f6f7abd8ebfc |
| institution | Directory Open Access Journal |
| issn | 2228-5806 2228-5814 |
| language | English |
| last_indexed | 2024-12-22T00:37:23Z |
| publishDate | 2021-09-01 |
| publisher | Royan Institute (ACECR), Tehran |
| record_format | Article |
| series | Cell Journal |
| spelling | doaj.art-3d4896fa721149aaa589f6f7abd8ebfc2022-12-21T18:44:47ZengRoyan Institute (ACECR), TehranCell Journal2228-58062228-58142021-09-0123439740510.22074/cellj.2021.7251Assessment of DAPK1 and CAVIN3 Gene Promoter Methylation in Breast Invasive Ductal Carcinoma and MetastasisEsmat Ghalkhani0Mohammad Taghi Akbari1Pantea Izadi2Habibollah Mahmoodzadeh3Fatemeh Kamali4Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IranDepartment of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IranDepartment of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Surgery, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, IranIran National Tumor Bank, Cancer Institute of Iran, Tehran, University of Medical Sciences, Tehran, Iranfor detection of distant metastasis have still some limitations. Blood tests may improve sensitivity and specificity of currently used screening procedures. The present study was designed to investigate promoter methylation status of DAPK1 and CAVIN3 genes in plasma circulating free DNA (cfDNA) samples in Iranian invasive ductal carcinoma (IDC) patients. We also investigated association of two gene promoter methylations with breast cancer (BC) and metastatic BC was also assessed. Materials and Methods: In this case-control study, MethySYBR assay was performed to determine DAPK1 and CAVIN3 promoter methylation status in breast IDC from 90 patients and 30 controls. Based on clinicopathological information, patient samples subdivided into stage I, II/III and IV groups (each group contained 30 individuals). Results: According to the results an increased promoter methylation level of the DAPK1 gene in BC patients was observed. It was found that as disease progressed, the percentage of methylation was changed while it was not significant. Methylation changes in metastatic and non-metastatic BC revealed that methylation levels were significantly increased in metastatic than non-metastatic group. Analysis revealed that promoter methylation of CAVIN3 gene in BC patients was significantly increased. The observed methylation changes from less to more invasive stages were not significant in the CAVIN3 gene. Moreover, promoter methylation was changed in metastatic rather than non-metastatic condition, although it was not significant. Conclusion: Promoter hypermethylation of DAPK1 and CAVIN3 genes in plasma are associated with the risk of BC and they can be potential diagnostic biomarkers along with current methods. Additionally, association of aberrant DAPK1 promoter methylation with metastasis suggests its potential usage as a non-invasive strategy for metastatic BC diagnosis.https://celljournal.org/journal/article/fulltext/assessment-of-dapk1-and-cavin3-genes-promoter-methylation-in-breast-invasive-ductal-carcinoma-incidence-and-metastasis.pdfbreast cancercavin3dapk1metastasismethylation |
| spellingShingle | Esmat Ghalkhani Mohammad Taghi Akbari Pantea Izadi Habibollah Mahmoodzadeh Fatemeh Kamali Assessment of DAPK1 and CAVIN3 Gene Promoter Methylation in Breast Invasive Ductal Carcinoma and Metastasis Cell Journal breast cancer cavin3 dapk1 metastasis methylation |
| title | Assessment of DAPK1 and CAVIN3 Gene Promoter Methylation in Breast Invasive Ductal Carcinoma and Metastasis |
| title_full | Assessment of DAPK1 and CAVIN3 Gene Promoter Methylation in Breast Invasive Ductal Carcinoma and Metastasis |
| title_fullStr | Assessment of DAPK1 and CAVIN3 Gene Promoter Methylation in Breast Invasive Ductal Carcinoma and Metastasis |
| title_full_unstemmed | Assessment of DAPK1 and CAVIN3 Gene Promoter Methylation in Breast Invasive Ductal Carcinoma and Metastasis |
| title_short | Assessment of DAPK1 and CAVIN3 Gene Promoter Methylation in Breast Invasive Ductal Carcinoma and Metastasis |
| title_sort | assessment of dapk1 and cavin3 gene promoter methylation in breast invasive ductal carcinoma and metastasis |
| topic | breast cancer cavin3 dapk1 metastasis methylation |
| url | https://celljournal.org/journal/article/fulltext/assessment-of-dapk1-and-cavin3-genes-promoter-methylation-in-breast-invasive-ductal-carcinoma-incidence-and-metastasis.pdf |
| work_keys_str_mv | AT esmatghalkhani assessmentofdapk1andcavin3genepromotermethylationinbreastinvasiveductalcarcinomaandmetastasis AT mohammadtaghiakbari assessmentofdapk1andcavin3genepromotermethylationinbreastinvasiveductalcarcinomaandmetastasis AT panteaizadi assessmentofdapk1andcavin3genepromotermethylationinbreastinvasiveductalcarcinomaandmetastasis AT habibollahmahmoodzadeh assessmentofdapk1andcavin3genepromotermethylationinbreastinvasiveductalcarcinomaandmetastasis AT fatemehkamali assessmentofdapk1andcavin3genepromotermethylationinbreastinvasiveductalcarcinomaandmetastasis |